About Our Grant Program

Our Hollis Brownstein Research Grants Program funds critical blood cancer research by providing one-year grants of up to $100K to new investigators – scientists who are establishing their own laboratories and are no longer under the tutelage of a senior scientist mentor. Supporting this critical research niche fosters new and innovative ideas that lead to significant breakthroughs and builds the next generation of scientific leaders.

Since 1946, the Leukemia Research Foundation has supported more than 600 blood cancer research projects across five continents. Learn more about our research impact.

How we select research projects

The Leukemia Research Foundation's independent Medical Advisory Board includes more than 30 hematology/oncology experts from prominent medical research institutions across the country. The Medical Advisory Board's primary function is to review research grant proposals and make funding recommendations to the Foundation.

The Medical Advisory Board uses the below criteria to review research proposals.


If the project will lead to new and innovative findings that contribute to leukemia, lymphoma, multiple myeloma, and/or myelodysplastic syndromes research.


What effect the study may have on how blood cancers are detected, diagnosed, and treated.


The training and preparedness of the applicant and their research setting.

Program supporters

The Hollis Brownstein Research Grants Program is supported in part by the following organizations.

Explore more

Our impact on blood cancer research

Medical Advisory Board

Grant eligibility + guidelines